Successful Salvage Haploidentical Bone Marrow Transplantation in a Child With Hemophagocytic Lymphohistiocytosis, When the Previously Matched Unrelated Donor Tested Positive for SARS-CoV-2 on the Day of Stem Cells Collection
暂无分享,去创建一个
W. Młynarski | R. Chaber | K. Kałwak | J. Musiał | Paweł Marschollek | K. Gul | Justyna Miśkiewicz-Bujna | Karolina Liszka
[1] J. Kanda,et al. Recent progress in haploidentical transplantation: is this the optimal choice for alternative donor transplantation? , 2019, Current opinion in hematology.
[2] N. Rastogi,et al. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Hemophagocytic Lymphohistiocytosis. , 2019, Journal of pediatric hematology/oncology.
[3] C. Klein,et al. T-cell replete haploidentical bone marrow transplantation and post-transplant cyclophosphamide for patients with inborn errors , 2019, Haematologica.
[4] A. Vekhoff,et al. Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] Y. Nakazawa,et al. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management , 2016, Pediatrics international : official journal of the Japan Pediatric Society.
[6] J. Styczyński,et al. Strategy of pre-emptive management of Epstein-Barr virus post-transplant lymphoproliferative disorder after stem cell transplantation: results of European transplant centers survey , 2012, Contemporary oncology.
[7] W. Shlomchik,et al. Graft-versus-host disease , 2007, Nature Reviews Immunology.
[8] M. Aricò,et al. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.
[9] M. Dürken,et al. Bone Marrow Transplantation in Hemophagocytic Lymphohistiocytosis , 2001, Leukemia & lymphoma.
[10] M. Shlomchik,et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.